Corient Private Wealth
GOSS icon

Corient Private Wealth’s Gossamer Bio GOSS Stock Holding History

Corient Private Wealth’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.31M Sell
3,985,383
-3,706,387
-48% -$5.83M ﹤0.01% 1488
2025
Q4 		$23.8M Buy
7,691,770
+7,671,764
+38,347% +$21.9M 0.02% 523
2025
Q3 		$52.6K Sell
20,006
-3,673,677
-99% -$8.1M ﹤0.01% 2496
2025
Q2 		$4.54M Buy
3,693,683
+302,200
+9% +$330K 0.01% 724
2025
Q1 		$3.73M Hold
3,391,483
– – 0.01% 764
2024
Q4 		$3.07M Hold
3,391,483
– – 0.01% 847
2024
Q3 		$3.35M Hold
3,391,483
– – 0.01% 886
2024
Q2 		$3.06M Buy
3,391,483
+119,213
+4% +$89.2K 0.01% 861
2024
Q1 		$3.86M Buy
3,272,270
+334,339
+11% +$368K 0.01% 782
2023
Q4 		$2.68M Buy
2,937,931
+965,092
+49% +$713K ﹤0.01% 882
2023
Q3 		$1.64M Buy
1,972,839
+602,653
+44% +$694K ﹤0.01% 987
2023
Q2 		$1.64M Buy
1,370,186
+9,800
+0.7% +$12.2K ﹤0.01% 963
2023
Q1 		$1.71M Buy
1,360,386
+1,191,666
+706% +$2.28M ﹤0.01% 897
2022
Q4 		$366K Buy
+168,720
New +$1.39M ﹤0.01% 1258

Other funds holding GOSS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Corient Private Wealth's GOSS Position: Q1 2026 in Review

Corient Private Wealth reduced its Gossamer Bio (GOSS) stake by 48% in Q1 2026, selling an estimated $5.83M and leaving 3,985,383 shares worth $1.31M. The position accounts for ﹤0.01% of the portfolio, ranked #1488.

Corient Private Wealth first reported a position in GOSS in Q4 2022 and has held it in 14 quarters since. The position peaked at $23.8M in Q4 2025. 184 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Corient Private Wealth held 3,985,383 shares of Gossamer Bio worth $1.31M as of Q1 2026.
  • Corient Private Wealth sold 3,706,387 Gossamer Bio shares in Q1 2026, an estimated $5.83M.
  • Gossamer Bio made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #1488 holding.
  • Corient Private Wealth first reported a position in Gossamer Bio in Q4 2022 and has held it in 14 quarters since.
  • Corient Private Wealth's Gossamer Bio position peaked at $23.8M in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.